{"id":50592,"date":"2023-09-20T09:10:28","date_gmt":"2023-09-20T09:10:28","guid":{"rendered":"https:\/\/medsname.com\/glinate\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"glinate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/glinate\/","title":{"rendered":"Glinate"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Glinate?<\/h3>\n<p style=\"margin:0;\"><strong>Glinate<\/strong> este o marc\u0103 a <strong>nateglinid\u0103<\/strong> (120 mg), un <strong>meglitinid\u0103 (\u201cglinid\u0103\u201d)<\/strong> utilizat pentru <strong>diabetului de tip 2<\/strong>. La fel ca sulfonilureele, glinidele stimuleaz\u0103 eliberarea de insulin\u0103 pancreatic\u0103 prin blocarea canalelor K<sub>Durata de ac\u021biune:<\/sub> canale \u2014 dar mult mai rapid \u0219i pentru un timp mult mai scurt. Nisa clinic\u0103: <strong>cre\u0219teri ale glicemiei postprandiale<\/strong>. Lua\u021bi 1\u201315 minute \u00eenainte de fiecare mas\u0103 principal\u0103; omite\u021bi doza dac\u0103 omite\u021bi masa (\u201cf\u0103r\u0103 mas\u0103, f\u0103r\u0103 pastil\u0103\u201d). Ac\u021biune mai rapid\u0103 dec\u00e2t repaglinida. Efect mai slab asupra HbA1c (0,5\u20130,8 puncte), dar ac\u021biune foarte bun\u0103 postprandial. Reducerea HbA1c: 0,5\u20131,0 puncte procentuale. Riscul de hipoglicemie este mult mai mic dec\u00e2t la sulfoniluree, deoarece ac\u021biunea este scurt\u0103. Efecte secundare principale: hipoglicemie u\u0219oar\u0103, cre\u0219tere \u00een greutate (1\u20132 kg), infec\u021bii ale tractului respirator superior. Evita\u021bi \u00een diabetul zaharat de tip 1, CAD, insuficien\u021b\u0103 hepatic\u0103 sever\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Glinate?<\/h2>\n<p>Glinate este un medicament antidiabetic oral care con\u021bine <strong>nateglinid\u0103<\/strong> (120 mg), fabricat de Glenmark Pharmaceuticals. Disponibil \u00een cutii de 30, 60, 90 sau 180 de comprimate. Nateglinida a fost aprobat\u0103 pentru prima dat\u0103 \u00een 2000 \u0219i apar\u021bine clasei <strong>meglitinide (sau \u201cglinide\u201d)<\/strong> \u2014 secretagogi de insulin\u0103 cu ac\u021biune scurt\u0103, utiliza\u021bi specific pentru controlul cre\u0219terilor glicemice postprandiale.<\/p>\n<p>Meglitinidele sunt o op\u021biune util\u0103 la pacien\u021bii cu predominant <strong>hiperglicemie postprandial\u0103<\/strong>, modele neregulate de mese (unde o sulfoniluree cu ac\u021biune lung\u0103 ar provoca hipoglicemie \u00een post), sau insuficien\u021b\u0103 renal\u0103 u\u0219oar\u0103 unde glibenclamida nu poate fi utilizat\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Glinate?<\/h2>\n<p>nateglinida se leag\u0103 de un situs pe canalul de potasiu (K<sub>Durata de ac\u021biune:<\/sub>) dependent de ATP al celulelor beta pancreatice \u2014 diferit de situsul de legare al sulfonilureelor, dar cu un efect similar. \u00cenchiderea canalului depolarizeaz\u0103 celula beta, deschide canalele de calciu dependente de tensiune \u0219i declan\u0219eaz\u0103 eliberarea de insulin\u0103.<\/p>\n<p>Diferen\u021ba cheie fa\u021b\u0103 de sulfoniluree este <strong>cinetic\u0103<\/strong>:<\/p>\n<ul>\n<li><strong>\u00cenceput:<\/strong> 15\u201330 de minute<\/li>\n<li><strong>V\u00e2rf:<\/strong> 1 or\u0103<\/li>\n<li><strong>Vildagliptina specific: rare cre\u0219teri ale enzimelor hepatice \u2014 monitoriza\u021bi ALT<\/strong> 3\u20134 ore<\/li>\n<li><strong>Timp de \u00eenjum\u0103t\u0103\u021bire:<\/strong> ~1,5 ore; metabolism hepatic cu ~80% excre\u021bie renal\u0103 a metaboli\u021bilor<\/li>\n<\/ul>\n<p>Acest lucru face ca glinidele s\u0103 fie excelente pentru a corespunde cre\u0219terii glicemiei postprandiale, dar ineficiente pentru controlul glicemiei \u00een post. Reducere tipic\u0103 a HbA1c: <strong>0,5\u20131,0 puncte procentuale<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Doza:<\/strong> 120 mg cu 1\u201330 de minute \u00eenainte de fiecare mas\u0103 principal\u0103. Poate fi redus\u0103 la 60 mg aproape de obiectiv sau ca doz\u0103 ini\u021bial\u0103 \u00een hiperglicemie u\u0219oar\u0103. Omite\u021bi dac\u0103 masa este omis\u0103.<\/p>\n<ul>\n<li><strong>\u201cF\u0103r\u0103 mas\u0103, f\u0103r\u0103 pastil\u0103.\u201d<\/strong> Dac\u0103 omite\u021bi o mas\u0103, omite\u021bi doza \u2014 altfel este probabil\u0103 hipoglicemia.<\/li>\n<li><strong>Dac\u0103 ad\u0103uga\u021bi o mas\u0103<\/strong>, ad\u0103uga\u021bi o doz\u0103 \u00eenainte.<\/li>\n<li>Lua\u021bi 1\u201330 de minute \u00eenainte de mas\u0103 \u2014 un program consistent ajut\u0103.<\/li>\n<li><strong>Dozare renal\u0103:<\/strong> Nu este necesar\u0103 ajustarea dozei \u00een insuficien\u021b\u0103 renal\u0103 u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103. Folosi\u021bi cu precau\u021bie \u00een insuficien\u021b\u0103 sever\u0103.<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103: utiliza\u021bi doze ini\u021biale mai mici \u0219i titra\u021bi cu precau\u021bie.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente:<\/strong><\/p>\n<ul>\n<li><strong>Hipoglicemie<\/strong> \u2014 mai pu\u021bin frecvente \u0219i mai pu\u021bin severe dec\u00e2t la sulfoniluree, dar totu\u0219i posibile (mai ales dac\u0103 masa este \u00eent\u00e2rziat\u0103 sau omis\u0103)<\/li>\n<li>Cre\u0219tere \u00een greutate \u2014 1\u20132 kg \u00een medie, mai pu\u021bin dec\u00e2t la sulfoniluree<\/li>\n<li>Infec\u021bii ale tractului respirator superior, sinuzit\u0103, artralgie<\/li>\n<li>Disconfort gastrointestinal u\u0219or<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> erup\u021bie cutanat\u0103, hipersensibilitate, cre\u0219tere tranzitorie a enzimelor hepatice.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Inhibitori puternici ai CYP3A4 (ketoconazol, claritromicin\u0103, ritonavir) \u0219i inhibitori ai CYP2C8 (gemfibrozil)<\/strong> \u2014 cresc semnificativ nivelurile de repaglinid\u0103. <strong>Evita\u021bi combinarea repaglinidei cu gemfibrozil<\/strong> (risc de hipoglicemie sever\u0103).<\/li>\n<li><strong>Rifampicin\u0103, fenitoin\u0103, carbamazepin\u0103<\/strong> \u2014 reduc nivelurile de meglitinide; efectul clinic poate fi diminuat.<\/li>\n<li><strong>Insulin\u0103, sulfoniluree, inhibitori DPP-4, inhibitori SGLT-2<\/strong> \u2014 efect hipoglicemiant aditiv; monitoriza\u021bi pentru hipoglicemie.<\/li>\n<li><strong>Beta-blocante neselective<\/strong> \u2014 pot masca simptomele de hipoglicemie.<\/li>\n<li><strong>AINS, salicila\u021bi \u00een doze mari, IMAO, sulfamide<\/strong> \u2014 pot amplifica efectul hipoglicemiant.<\/li>\n<li><strong>Corticoizi, tiazide, hormoni tiroidieni, contraceptive orale<\/strong> \u2014 pot reduce efectul hipoglicemiant.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cine nu ar trebui s\u0103 ia Glinate?<\/h2>\n<ul>\n<li>Diabet zaharat de tip 1<\/li>\n<li>Cetoacidoz\u0103 diabetic\u0103<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103<\/li>\n<li>Sarcin\u0103 \u0219i al\u0103ptare \u2014 date limitate; se prefer\u0103 alternative<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la meglitinide.<\/li>\n<li>Combina\u021bie cu gemfibrozil (repaglinid\u0103)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Glinate la o temperatur\u0103 sub 30\u00b0C, \u00eentr-un loc uscat. Depozita\u021bi \u00een afara reach-ului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar alege un medic nateglinid\u0103 \u00een loc de repaglinid\u0103?<\/h3>\n<p>Nateglinida are un efect mai rapid \u0219i o durat\u0103 mai scurt\u0103 dec\u00e2t repaglinida, a\u0219a c\u0103 este uneori aleas\u0103 atunci c\u00e2nd cre\u0219terile glicemiei postprandiale sunt principala problem\u0103 \u0219i glicemia \u00een post este deja aproape de \u021bint\u0103. Repaglinida este mai des utilizat\u0103 deoarece are un efect mai mare de sc\u0103dere a HbA1c \u0219i o durat\u0103 u\u0219or mai lung\u0103 care este mai u\u0219or de titrat.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 omit o mas\u0103?<\/h3>\n<p>Omite\u021bi \u0219i doza de Glinate \u2014 regula de aur pentru glinide este \u201cf\u0103r\u0103 mas\u0103, f\u0103r\u0103 pastil\u0103\u201d. Administrarea Glinate f\u0103r\u0103 a m\u00e2nca este cea mai frecvent\u0103 cauz\u0103 de hipoglicemie la acest medicament.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Glinate cu metformin\u0103?<\/h3>\n<p>Da \u2014 glinidele sunt adesea ad\u0103ugate la metformin\u0103 atunci c\u00e2nd cre\u0219terile glicemiei postprandiale sunt mari. Combina\u021bia are un efect aditiv asupra HbA1c (0,8\u20131,2 puncte \u00een plus) f\u0103r\u0103 riscul de hipoglicemie \u00een post asociat sulfonilureelor cu ac\u021biune prelungit\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Glinate provoac\u0103 cre\u0219tere \u00een greutate?<\/h3>\n<p>O u\u0219oar\u0103 cre\u0219tere \u00een greutate de 1\u20132 kg este tipic\u0103 \u2014 mai pu\u021bin dec\u00e2t \u00een cazul sulfonilureelor, dar mai mult dec\u00e2t la metformin\u0103, inhibitorii DPP-4 sau inhibitorii SGLT-2.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 consum alcool \u00een timp ce iau Glinate?<\/h3>\n<p>Consumul moderat de alcool \u00een combina\u021bie cu alimente este de obicei sigur. Evita\u021bi consumul excesiv de alcool \u0219i consumul de alcool pe stomacul gol \u2014 ambele cresc riscul de hipoglicemie.<\/p>\n<h3 class=\"wp-block-heading\">Este Glinate potrivit dac\u0103 am probleme renale?<\/h3>\n<p>Repaglinida este meglitinida preferat\u0103 \u00een cazul insuficien\u021bei renale, deoarece este eliminat\u0103 aproape \u00een totalitate de ficat. Nateglinida are metaboli\u021bi elimina\u021bi renal \u0219i necesit\u0103 mai mult\u0103 pruden\u021b\u0103 \u00een cazul BCR sever.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Glinate online?<\/h3>\n<p>Pute\u021bi comanda Glinate (120 mg) de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Livr\u0103m \u00een \u00eentreaga lume, cu ambalaj discret \u0219i stocuri autentice de la produc\u0103tori certifica\u021bi WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru Diabet<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR \u2014 Metformin cu eliberare prelungit\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/januvia\/\">Januvia \u2014 Sitagliptin\u0103 (inhibitor DPP-4)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin\u0103 (inhibitor SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amaryl\/\">Amaryl \u2014 Glimepirid\u0103 (alternativ\u0103 sulfonilureic\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glucobay\/\">Glucobay \u2014 Acarboz\u0103 (alternativ\u0103 \u03b1-glucosidaz\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\"><strong>Vizualiza\u021bi toate Medicamentele pentru Diabet<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat din domeniul s\u0103n\u0103t\u0103\u021bii. Utiliza\u021bi \u00eentotdeauna meglitinide sub \u00eendrumare medical\u0103, cu monitorizare regulat\u0103 a glicemiei.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipril-h\/\">Lipril-H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/brom\/\">Brom<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losatec-h\/\">Losatec H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glynase-xl\/\">Glynase Xl<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Stimuleaz\u0103 secre\u021bia de insulin\u0103<br \/>\n\u2705 Ac\u021biune rapid\u0103<br \/>\n\u2705 Rapid onset of action<br \/>\n\u2705 Reduce v\u00e2rfurile de glicemie postprandial\u0103<br \/>\n\u2705 Program de administrare convenabil<\/h5>\n<p><span style=\"color: #999999;\">Glinate con\u021bine Nateglinide<\/span><\/p>","protected":false},"featured_media":50593,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3244,3245],"class_list":{"0":"post-50592","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glinate","11":"product_tag-nateglinide","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/50592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=50592"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/50593"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=50592"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=50592"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=50592"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=50592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}